Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Conduct / Assessment of BE [Design Issues]

posted by joyjac – Philippines, 2006-05-23 05:50 (7328 d 03:19 ago) – Posting: # 134
Views: 11,306

Dear HS,

How would you conduct/assess BE of 2 drug products of the same active ingredient but of different dosage formats and strengths i.e. immediate-release, 130 mg per tablet versus sustained-release, 200 mg per tablet? Thanks.

Complete thread:

Conduct / Assessment of BEjoyjac 2006-05-23 03:50
- BE of MR versus IR? Helmut 2006-05-28 13:28
  - Comparative BA versus BE? drks 2006-12-18 15:21
    - Comparative BA versus BE? Helmut 2006-12-18 15:54

Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
237 visitors (0 registered, 237 guests [including 134 identified bots]).
Forum time: 09:09 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another. Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz